QUEBEC CITY, April 15, 2025--(BUSINESS WIRE)--Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), announces that the Autorité des ...

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), announces that the Autorité des Marchés Financiers (the “AMF”) has issued a failure to file cease ...

Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to inflammatory diseases, today ...

Devonian Health Group Inc. Mr. Luc Grégoire President and Chief Executive Officer Telephone: 1 (450) 979-2916 E-mail: [email protected] Renmark Financial Communications Inc. Mr. Ben ...

“Devonian continued to improve its financial position in the second fiscal quarter ended January 31, 2025,” said Luc Gregoire, President and Chief executive Officer of Devonian. “The operating cash ...